CanWell Pharma Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors (NCT04987112) | CanWell Pharma Inc. | 2022-01-20 |
Track CanWell Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.